Yong Oon Ahn

Yong Oon Ahn

Columbia University New York - New York / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 913155
person_outline Yong Oon Ahn's MOST POPULAR ARTICLES
1-) Mechanisms of acquired resistance to AZD9291: a mutation-selective, irreversible EGFR inhibitorTM Kim, A Song, DW Kim, S Kim, YO Ahn, B Keam, YK Jeon, SH Lee, ...Journal of Thoracic Oncology 10 (12), 1736-1744, 20152032015
2-) Phase I study of random healthy donor–derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumorsY Yang, O Lim, TM Kim, YO Ahn, H Choi, H Chung, B Min, JH Her, ...Cancer immunology research 4 (3), 215-224, 20161332016
3-) Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinomaCY Ock, S Kim, B Keam, S Kim, YO Ahn, EJ Chung, JH Kim, TM Kim, ...Oncotarget 8 (58), 97920, 2017862017
4-) CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive functionJ Choi, B Suh, YO Ahn, TM Kim, JO Lee, SH Lee, DS HeoTumor Biology 33, 121-129, 2012872012
5-) Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinomaSH Kang, B Keam, YO Ahn, HR Park, M Kim, TM Kim, DW Kim, DS HeoOncoimmunology 8 (1), e1515057, 2019712019